Another immunosuppressive ligand on tumor cells, the herpes virus entry mediator (HVEM), that has been shown to be expressed in the microenvironment of GBM, driving Treg induction and stronger immunosuppression, is correlated with a reduced outcome in patients if overexpressed in the GBM tissue [21]. This evidence concerns the gene TNFRSF14 and glioblastoma.